Floatz logo

(18F)-FP-(+)-DTBZ

Type 2 Diabetes

Avid RadiopharmaceuticalsSmall moleculePhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
73/ 100

Competitive context

142 Active assets in the Type 2 Diabetes cohort.

Asset / SponsorPhaseRating
Semaglutide
Shanghai Jiao Tong University School of Medicine
Phase 4BBB
Liraglutide
RenJi Hospital
Phase 4BBB
Dapagliflozin
Bhavya Bhavya, MD
Phase 4BBB
Exenatide
Vivani Medical, Inc
Phase 4BBB
Cotadutide
AstraZeneca
Phase 2BBB

View all 50 →

Same molecule, other indications

(18F)-FP-(+)-DTBZ is also rated in:

Parkinson diseaseDormant
BBB
Indicative ·
74 / 100
View asset →
Lewy body dementiaDormant
BB
Indicative ·
65 / 100
View asset →
Alzheimer diseaseDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →